1600201

Regorafenib

United States Pharmacopeia (USP) Reference Standard

• 別名: Regorafenib monohydrate, 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide monohydrate
• 実験式（ヒル表記法）: C₂₁H₁₅ClF₄N₄O₃ · H₂O
• CAS番号: 1019206-88-2
• 分子量: 500.83
• MDL番号: MFCD17170366
• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• APIファミリー: regorafenib
• メーカー／製品名: USP
• アプリケーション: pharmaceutical (small molecule)
• フォーマット: neat
• 保管温度: 15-25°C
• SMILES記法: FC(F)(F)c1c(ccc(c1)NC(=O)Nc2c(cc(cc2)Oc3cc(ncc3)C(=O)NC)F)Cl.O
• InChI: 1S/C21H15ClF4N4O3.H2O/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26;/h2-10H,1H3,(H,27,31)(H2,29,30,32);1H2
• InChI Key: ZOPOQLDXFHBOIH-UHFFFAOYSA-N

詳細

詳細

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

アプリケーション

Regorafenib USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.

アナリシスノート

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  

その他情報

Sales restrictions may apply.

安全性情報

• ピクトグラム: GHS08,GHS09
• シグナルワード: Warning
• 危険有害性情報: H361fd,H373,H410
• 注意書き: P202 - P260 - P273 - P280 - P308 + P313 - P391
• 危険有害性の分類: Aquatic Acute 1 - Aquatic Chronic 1 - Repr. 2 - STOT RE 2
• ターゲットの組織: Liver
• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable